Healthcare Marketing Summit 2025

Navigating Complexities, Risks and Opportunities Responsibly

With rising demand driven by an aging population, chronic disease management and wellness trends, the healthcare marketing space presents significant opportunities for agency growth. Healthcare is one of the most complex and heavily regulated industries—and one of the most lucrative. In 2023, the U.S. spent $4.9 trillion on healthcare—17.6% of GDP.  

Yet for agencies unfamiliar with the terrain, breaking in can be daunting. And for agencies already in the space, the challenges, complexities and risks continue to evolve alongside the opportunity. Recent communications from the administration indicating increased scrutiny of direct-to-consumer (DTC) and health care provider (HCP) prescription drug advertising have raised new questions.

The 4As Healthcare Marketing Summit is an opportunity to gain a better understanding of this landscape and learn to unlock its potential with informed clarity and confidence.  We will also be sharing our response action plan to help agencies navigate the administration’s recent communications around Rx advertising. 

Free Half-Day Event | October 9 | NYC

Learn to navigate the complex and constantly shifting world of healthcare marketing. 

At the 4As-CHC Healthcare Marketing Summit, you’ll discover critical insights into the evolving role of government in healthcare funding, the convergence of wellness and traditional care, the growing opportunities and risks of AI and data-driven marketing and more. Join leading minds from across the industry as we examine what’s next in strategy, compliance and growth across the healthcare and wellness landscape. Walk away with the insight you need to shape smarter, future-ready healthcare marketing strategies. Register today!

Agenda

9:00 AM – 9:45 AM – The Big Picture – Government’s Role Is Healthcare Is Going To Get Bigger In The Coming Years. How Will We Pay For It?
Despite recent budget cuts to Medicaid, medical research, and tax subsidies for state marketplace exchange participants, the long-term trend lines continue to suggest more government involvement in healthcare in the decades ahead.
A combination of an aging U.S. population, the rising unaffordability of health insurance for even the fully-employed with access to employer-provided coverage, and the growth of new offerings in the device and pharmaceutical space will all contribute to roll-up to the big policy question – who is going to pay for all this, and how?
Join our panelists as we dive into how we got here, and where we might be headed.

Panelists
Jim Potter – Executive Director @ CHC

Eric Densmore – SVP Business Strategy @ AbelsonTaylor

Jameson Fleming – Editor-in-Chief @ MM + M (Moderator)

9:00 – 10:00 AM – Break

10:00 AM – 10:45 AM – Healthcare vs. Wellness Markets – What’s The Difference?
While legal might have a snappy response to this question (i.e. regulated vs. unregulated), the distinction between these two markets seems to both be somehow expanding and contracting.
The explosion of wearables with tracking technologies (including a new HHS head who has said he wants to see all Americans wearing one in the next decade) as well as the growth of new markets like sleep wellness and other health wearables begs the question – what exactly are the differences between the healthcare and wellness markets, and why does it matter to marketers?

Panelists
Jay Carter – EVP, Business Development @ CG Life

Chris Paquette – CEO @ DeepIntent

Jill Mastroianni – Managing Director & Global CMO @ Grey Health

Ashwini Karandikar – EVP, Media, Technology & Data @ 4As (Moderator)

10:50 AM – 11:30 AM – Healthcare Data Everywhere, All The Time – What Are The Opportunities And The Risks?
The explosion of healthcare data availability in the past decade, as well as new tools like AI to harness all that data, raises a lot of new opportunities.
Whether it’s cutting edge new immunotherapy developments for cancer treatment or fitness trackers predicting the optimal time to exercise or eat, there’s never been more opportunity to harness all that new data swirling around for significant patient benefit.
And with the recent announcement by CMS to engage in a public-private partnership with companies like Google, Amazon, Apple, etc. to develop a framework for seamless sharing of data between patients and providers, it seems that momentum is building to capitalize on this explosion of available data.
But along with the promise of this new pool of data and tools, comes new risks, and policymakers have been taking note.
What specifically are policymakers concerned with when it comes to healthcare data privacy, and how might it impact future product development and marketing?

Panelists
Jonathan C. Margulies – Managing Partner @ Winterberry Group

Rob Engel – General Counsel @ DeepIntent

Jean Hitchcock – Senior Marketing Advisor @ Digital Health Strategies

11:35 AM – 12:00 PM – Wrap-Up

Panelists
Alison Pepper – EVP, Government Relations @ 4As

Jim Potter – Executive Director @ CHC

Ashwini Karandikar – EVP, Media, Technology & Data @ 4As (Moderator)